3647 results for «604»
3647 results
Technical challenges and optimal device choice for complex TAVI procedures
18 Feb 2023 – From PCR Tokyo Valves 2023
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Uncover challenges in TAVI for failed bioprostheses and bicuspid aortic valves, emphasising optimal device selection and exploring the latest evolutions in TAVI such as the Medtronic.
Bicuspid valves - Imaging, sizing and technical considerations for success
18 Feb 2023 – From PCR Tokyo Valves 2023
Watch this session to learn more about bicuspid aortic valves: understand the anatomical considerations that define patient selection, explore contemporary sizing strategies and participate in case-based discussions that highlight treatment strategies for bicuspid aortic stenosis.
Predictability and control: Evolut procedural approaches
18 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into Evolut procedural approaches. You will be examining the cusp overlap technique, its latest clinical data and outcomes of the Medtronic's newest generational technology: Evolut FX.
Factors to consider during lifetime planning for TAVI patients
19 Feb 2023 – From PCR Tokyo Valves 2023
In this session, explore factors influencing lifetime prognosis and complication avoidance strategies in TAVI patients, focusing on pacemaker and paravalvular leak risk factors.
Which AF patients may benefit from LAA closure?
02 Jul 2026
Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
